SCHEMBL28601857

SCHEMBL28601857

CC(C)(COC(N)=O)NC(=O)OC(C)(C)C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.43
HSD17B10 Q99714 1/20 0.43
TSHR P16473 2/20 0.40
TDP1 Q9NUW8 2/20 0.40
CYP3A4 P08684 1/20 0.40
NFKB1 P19838 1/20 0.40
ADRA1A P35348 1/20 0.40
RAB9A P51151 1/20 0.40
MAOA P21397 1/20 0.38
MAOB P27338 1/20 0.38
CA12 O43570 5/20 0.36
CA14 Q9ULX7 3/20 0.36
ALOX15 P16050 1/20 0.35
CA1 P00915 4/20 0.35
CA2 P00918 4/20 0.35
CA7 P43166 2/20 0.35
MEN1 O00255 1/20 0.34
GAA P10253 1/20 0.34
KMT2A Q03164 1/20 0.34
CA9 Q16790 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6318013 0.83 TDP1 (0.37) LMNAHSD17B10TDP1MAOAMAOB
SCHEMBL21187934 0.81 TDP1 (0.38) TDP1MAOAMAOBCA12CA14
SCHEMBL25736759 0.79 TSHR (0.38) HSD17B10TSHRTDP1MAOAMAOB
SCHEMBL7923566 0.79 CA2 (0.42) TDP1MAOAMAOBCA12CA14
SCHEMBL9281818 0.77 MAOA (0.44) TDP1MAOAMAOBCA12CA14
SCHEMBL1437011 0.76 TDP1 (0.40) TDP1MAOAMAOBCA12CA14
SCHEMBL25736714 0.76 CA2 (0.33) TSHRTDP1CA12CA14CA1
SCHEMBL21261831 0.76 TDP1 (0.42) TDP1MAOAMAOBCA12CA14
SCHEMBL19400336 0.76 MAOA (0.39) TDP1MAOAMAOBCA12CA14
SCHEMBL89258 0.76 CA1 (0.38) TSHRTDP1MAOAMAOBCA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113631538-B Novel potassium channel inhibitors 萨尼奥纳有限责任公司 2024-05-31 CN disclosed
CN-114072412-B Tricyclic compound, pharmaceutical composition and application thereof 深圳铂立健医药有限公司 2023-01-10 CN disclosed
CN-114072412-A Tricyclic compound, pharmaceutical composition and application thereof 深圳铂立健医药有限公司 2022-02-18 CN disclosed
CN-113631538-A Novel potassium channel inhibitors 萨尼奥纳有限责任公司 2021-11-09 CN disclosed
CN-113214294-A Tricyclic compound, pharmaceutical composition and application thereof 深圳铂立健医药有限公司 2021-08-06 CN disclosed